Analysts’ updated eps estimates for Wednesday, February 25th:
Abivax (NASDAQ:ABVX) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $150.00 target price on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $325.00 price target on the stock.
ASML (NASDAQ:ASML) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft.
ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at Sanford C. Bernstein.
Carlyle Secured Lending (NASDAQ:CGBD) was upgraded by analysts at B. Riley Financial, Inc. from a neutral rating to a buy rating. B. Riley Financial, Inc. currently has $13.00 target price on the stock.
DexCom (NASDAQ:DXCM) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $85.00 price target on the stock.
Enphase Energy (NASDAQ:ENPH) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. They currently have $57.00 price target on the stock, up from their previous price target of $42.00.
FOX (NASDAQ:FOX) had its underperform rating reiterated by analysts at Bank of America Corporation. The firm currently has a $45.00 target price on the stock, down from their previous target price of $80.00.
First Solar (NASDAQ:FSLR) had its hold rating reaffirmed by analysts at HSBC Holdings plc. They currently have a $211.00 target price on the stock, down from their previous target price of $280.00.
First Solar (NASDAQ:FSLR) had its neutral rating reissued by analysts at Robert W. Baird. The firm currently has a $205.00 target price on the stock, down from their previous target price of $264.00.
Harmony Biosciences (NASDAQ:HRMY) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $55.00 target price on the stock.
International Business Machines (NYSE:IBM) was upgraded by analysts at UBS Group AG from a sell rating to a neutral rating. The firm currently has $236.00 target price on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) was upgraded by analysts at Citizens Jmp from a market perform rating to a market outperform rating. They currently have $5.00 target price on the stock.
Lincoln National (NYSE:LNC) was upgraded by analysts at Wells Fargo & Company from an equal weight rating to an overweight rating. The firm currently has $48.00 price target on the stock, up from their previous price target of $41.00.
Liquidia (NASDAQ:LQDA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $52.00 price target on the stock.
Larimar Therapeutics (NASDAQ:LRMR) had its outperform rating reissued by analysts at Wedbush. They currently have a $11.00 target price on the stock.
MannKind (NASDAQ:MNKD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $11.00 target price on the stock.
Neptune Insurance (NYSE:NP) was upgraded by analysts at Mizuho from an underperform rating to a neutral rating. The firm currently has $24.00 target price on the stock, down from their previous target price of $26.00.
NetApp (NASDAQ:NTAP) had its neutral rating reissued by analysts at Wedbush. Wedbush currently has a $115.00 price target on the stock.
Oracle (NYSE:ORCL) was upgraded by analysts at Oppenheimer Holdings, Inc. from a market perform rating to an outperform rating. They currently have $185.00 price target on the stock.
Principal Financial Group (NYSE:PFG) was upgraded by analysts at Wells Fargo & Company from an underweight rating to an equal weight rating. The firm currently has $91.00 price target on the stock, up from their previous price target of $85.00.
Revolve Group (NYSE:RVLV) had its buy rating reiterated by analysts at Roth Mkm. Roth Mkm currently has a $33.00 target price on the stock, up from their previous target price of $30.00.
Shoals Technologies Group (NASDAQ:SHLS) was upgraded by analysts at BNP Paribas Exane from an underperform rating to a neutral rating. The firm currently has $9.00 target price on the stock.
Taboola.com (NASDAQ:TBLA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $4.50 target price on the stock.
Thermon Group (NYSE:THR) had its market perform rating reaffirmed by analysts at William Blair.
Tennant (NYSE:TNC) had its buy rating reissued by analysts at Roth Mkm. Roth Mkm currently has a $91.00 target price on the stock, down from their previous target price of $107.00.
Trex (NYSE:TREX) was upgraded by analysts at Loop Capital from a hold rating to a buy rating. The firm currently has $53.00 target price on the stock, up from their previous target price of $45.00.
Unusual Machines (NYSEAMERICAN:UMAC) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $20.00 price target on the stock.
Workday (NASDAQ:WDAY) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $300.00 target price on the stock.
Receive News & Ratings for Abivax SA Sponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abivax SA Sponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
